Tagged with Mexico

Healthcare In part two of a two-part interview (read part one here), Mikel Arriola of the IMSS discusses the strategic roadmap IMSS will follow under his tenure with regards to innovation access and chronic disease prevention, as well as his approach to the upcoming implementation of exchanges of services among the…

Healthcare In part one of a two-part interview (read part two here), Mikel Arriola, the recently appointed general director of IMSS (Mexican Social Security Institute), which provides health-related services to more than 70 million beneficiaries, reveals his fundamental priorities to both secure IMSS’ financial sustainability and improve the quality of services…

Pharma Rafael Suarez, general manager of Ferring in Mexico, explains how the Swiss biopharmaceutical company is adapting to the recent dynamics affecting both the Mexican public and private sectors. He outlines his approach to further consolidate the Mexican affiliate, increase Ferring’s clinical research investments and manufacturing presence in Mexico. When Pharmaceutical…

Pharma Dr. Teresa Corona Vázquez, the general director of one of the leading neuroscience institutions in Latin America, details their most important research partnerships and achievements, notably with regards to neurodegenerative diseases, and her expectations of fostering a heightened research-based relationship with the pharmaceutical industry. What have been some of the…

Pharma Building on the continuous improvements of the Federal Commission for the Protection Against Sanitary Risk (Cofepris) over the last few years, its recently-appointed Federal Commissioner Julio Sánchez y Tépoz reveals his strategy to further strengthen and develop the Commission’s processes and international leadership, and foster a more transparent, technical, efficient…

Pharma Socorro España Lomelí, executive director of Mexico’s National Association of Drug Manufacturers (ANAFAM), details her strategic priorities with regards to the promotion of the industry’s export strategy, the implementation of world-class manufacturing norms, the development of biosimilars and API manufacturing, as well as recognizing the pharmaceutical sector as a strategic…

Pharma Rafael Gual, general director of CANIFARMA, the chamber that brings together multinational and local drug manufacturers, details how the organization is currently intensifying its efforts to ensure the pharmaceutical industry as a whole is officially recognized as a strategic Mexican industry by both the Ministries of Health and Economy, while…

Health Although the country is moving in the right direction with regards to universal coverage, a number of barriers to effective implementation remain. 57.3 million previously uninsured Mexicans are now enrolled in Seguro Popular Gabriel O’Shea, Seguro Popular Healthcare is one of the next items on President Peña Nieto’s busy agenda.…

Pharma Click here to read more articles and interviews from Peru, and to download the latest free pharma report on the country. 

Mexico The following charts show manufacturing costs in the Medical Devices Industry (compared to the US in 2013) and Medical Device Exports from Mexico (in USD millions). For more data on the Mexican market, please download our latest 2015 free report here.

Mexico The below chart shows the average number of days taken to grant registration for innovative drugs. The previous number of days for Mexico (360) has been greatly reduced to 60 as of 2014. For more data on the Mexican market, please download our latest 2015 free report here.

Mexico The chart below shows the main investors into pharmaceuticals in Mexico and the main export destinations for Mexican pharmaceutical products. It also shows the production value, compound annual growth, and number of economic units in the Mexican pharmaceutical industry, as well as the number of jobs it creates and overall FDI. For more data on the Mexican…